Literature DB >> 1494525

Complications associated with percutaneous needle biopsy of the liver when one, two or three specimens are taken.

B Maharaj1, I G Bhoora.   

Abstract

The diagnostic yield of blind percutaneous liver biopsy is improved when two or three specimens are taken during the procedure by redirecting the needle through a single entry-site, without exposing the patient to a greater risk of complications provided that standard precautions are taken. This study was designed to obtain further data on the safety of this procedure at King Edward VIII Hospital, Durban. During the period 1984-1990 (inclusive) a total of 2,646 biopsies were carried out: a single specimen was obtained in 834 patients, two specimens in 983 patients and three in 829 patients. Complications directly attributable to the procedure occurred in 24 patients who had one specimen, 20 who had two, and 19 who had three specimens taken during the biopsy. A single specimen had been obtained from three of the eight patients who had died, two specimens had been taken from another patient, and three specimens were obtained from the other four patients, i.e. patients in whom two or three specimens were taken did not have a higher incidence of pain, symptomatic hypotension, biliary peritonitis or death than those in whom one specimen was taken. Accordingly, when blind percutaneous needle biopsy of the liver is carried out, two specimens should be obtained by redirecting the needle through a single entry site as this improves the diagnostic yield without increasing complications. The morbidity and mortality associated with liver biopsy in this hospital is, however, high. Good technique, careful monitoring of patients after biopsy and prompt and aggressive resuscitation are essential if the mortality rate is to be reduced.

Entities:  

Mesh:

Year:  1992        PMID: 1494525      PMCID: PMC2399495          DOI: 10.1136/pgmj.68.806.964

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  6 in total

1.  'Tru-Cut' needle biopsy of the liver: importance of the correct technique.

Authors:  B Maharaj; S Pillay
Journal:  Postgrad Med J       Date:  1991-02       Impact factor: 2.401

2.  Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver.

Authors:  B Maharaj; R J Maharaj; W P Leary; R M Cooppan; A D Naran; D Pirie; D J Pudifin
Journal:  Lancet       Date:  1986-03-08       Impact factor: 79.321

3.  Percutaneous ultrasonography-guided cutting biopsy from liver metastases of endocrine gastrointestinal tumors.

Authors:  T Andersson; B Eriksson; P G Lindgren; E Wilander; K Oberg
Journal:  Ann Surg       Date:  1987-12       Impact factor: 12.969

4.  Causes of hepatomegaly at King Edward VIII Hospital, Durban. A prospective study of 240 black patients.

Authors:  B Maharaj; R M Cooppan; R J Maharaj; D K Desai; H A Ranchod; F M Siddie-Ganie; M B Goqwana; A S Ganie; M S Gaffar; W P Leary
Journal:  S Afr Med J       Date:  1986-02-01

5.  A prospective study of hepatic tuberculosis in 41 black patients.

Authors:  B Maharaj; W P Leary; D J Pudifin
Journal:  Q J Med       Date:  1987-06

6.  Liver biopsy: complications in 1000 inpatients and outpatients.

Authors:  J Perrault; D B McGill; B J Ott; W F Taylor
Journal:  Gastroenterology       Date:  1978-01       Impact factor: 22.682

  6 in total
  13 in total

1.  Guidelines on the use of liver biopsy in clinical practice. British Society of Gastroenterology.

Authors:  A Grant; J Neuberger
Journal:  Gut       Date:  1999-10       Impact factor: 23.059

2.  Acute pancreatitis secondary to hemobilia after percutaneous liver biopsy.

Authors:  Luis R Peña; Todd L Horn; Christopher B Cross
Journal:  Therap Adv Gastroenterol       Date:  2009-05       Impact factor: 4.409

3.  Who should be performing liver biopsies?

Authors:  C N Ghent
Journal:  Can J Gastroenterol       Date:  2009-06       Impact factor: 3.522

Review 4.  Pro: Noninvasive Imaging Has Replaced Biopsy as the Gold Standard in the Evaluation of Nonalcoholic Fatty Liver Disease.

Authors:  Shaham Mumtaz; Nathan Schomaker; Natasha Von Roenn
Journal:  Clin Liver Dis (Hoboken)       Date:  2019-04-30

5.  Organ Procurement Organization Survey of Practices and Beliefs Regarding Prerecovery Percutaneous Liver Biopsy in Donation After Neurologic Determination of Death.

Authors:  Joseph Benton Oliver; Andrea Fleisch Marcus; Mark Paster; Joseph Nespral; Advaith Bongu; George Dikdan; Lloyd Brown; Nikole Neidlinger; Baburao Koneru
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

6.  Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London.

Authors:  I T Gilmore; A Burroughs; I M Murray-Lyon; R Williams; D Jenkins; A Hopkins
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

Review 7.  Why, who and how should perform liver biopsy in chronic liver diseases.

Authors:  Ioan Sporea; Alina Popescu; Roxana Sirli
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

8.  Hemobilia Causing Acute Cholecystitis and Pancreatitis after Percutaneous Liver Biopsy: A Case Report and Review of the Literature.

Authors:  Nimet Yilmaz
Journal:  Visc Med       Date:  2019-10-08

Review 9.  Nonalcoholic Fatty Liver Disease Among Individuals with HIV Mono-infection: A Growing Concern?

Authors:  Margaret Morrison; Heather Y Hughes; Susanna Naggie; Wing-Kin Syn
Journal:  Dig Dis Sci       Date:  2019-10-23       Impact factor: 3.199

10.  Wedge and needle liver biopsies show discordant histopathology in morbidly obese patients undergoing Roux-en-Y gastric bypass surgery.

Authors:  Sekou R Rawlins; Cynthia M Mullen; Howard M Simon; Taewan Kim; Steven K Landas; Marguerite S Walser; Robert A Levine
Journal:  Gastroenterol Rep (Oxf)       Date:  2013-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.